NCT03356327

Brief Summary

A pilot, randomized, case-controlled trial was conducted in 60 children affected by AG (\< 7 days) with mild-moderate dehydration, according to WHO recommendations, from1 year to 17 years old. Patients were divided into 2 Groups: Group 1 consisting of 30 children treated with Actitan F and standard oral rehydration (SOR); Group 2 consisting of 30 children who received only SOR. Both groups received treatment for seven days, respectively. Patients of Group 1 stopped for their own choice, SOR after the first 24 h and continued only with Actitan F.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Apr 2017

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

November 16, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 29, 2017

Completed
Last Updated

November 29, 2017

Status Verified

November 1, 2017

Enrollment Period

4 months

First QC Date

November 16, 2017

Last Update Submit

November 28, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • effectiveness of a medical device made of Actitan-F in the treatment of acute diarrhea, valuated on the basis of consistency of stools based on Bristol Stool Form

    the effectiveness of a medical device made of Actitan-F, a natural molecular complex of tannins (from Agrimony and Tormentil) and flavonoids (Chamomile), in the treatment of acute gastroenteritis (AG) in children, valuated on the basis of stool consistency

    2 weeks

  • effectiveness of a medical device made of Actitan-F in the treatment of acute diarrhea, valuated on the basis of number of stools / day

    he effectiveness of a medical device made of Actitan-F, a natural molecular complex of tannins (from Agrimony and Tormentil) and flavonoids (Chamomile), in the treatment of acute gastroenteritis (AG) in children, valuated on the basis of number of stools/day

    2 weeks

Study Arms (2)

Group 1

EXPERIMENTAL

Group 1 consisting of 30 children treated with Actitan F and standard oral rehydration (SOR)

Drug: Actitan FDrug: Standard Oral Rehydration

Group 2

ACTIVE COMPARATOR

Group 2 consisting of 30 children who received only SOR.

Drug: Standard Oral Rehydration

Interventions

A molecolar complex of Tannins and Flavonoids used for acute diarrhea in children

Group 1

Standard oral rehydration as suggested by ESPGHAN guidelines

Group 1Group 2

Eligibility Criteria

Age3 Months - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Patients enrolled were children from 3 months to 12 years old, with a diagnosis of acute diarrhea appeared less than 7 days before the admission, capability to oral rehydration, mild to moderate dehydration.

You may not qualify if:

  • Patients with diarrhea over 7 days, serious somatic pathology and severe dehydration were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marina Russo

Napoli, 80131, Italy

Location

Related Publications (1)

  • Russo M, Coppola V, Giannetti E, Buonavolonta R, Piscitelli A, Staiano A. Oral administration of tannins and flavonoids in children with acute diarrhea: a pilot, randomized, control-case study. Ital J Pediatr. 2018 Jun 4;44(1):64. doi: 10.1186/s13052-018-0497-6.

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 16, 2017

First Posted

November 29, 2017

Study Start

April 1, 2017

Primary Completion

July 31, 2017

Study Completion

November 1, 2017

Last Updated

November 29, 2017

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will not share

Locations